Dietary cholestin (red yeast extract) reduces toxicity of oxidized cholesterol in rats

Journal of Food and Drug Analysis

Volumn 18, Issue 3, 2010, Pages

  Yeh, Yen Hung ^a   Lee, Ya Ting ^b   Hsieh, Hung Sheng ^c   Hwang, Deng Fwu ^d  

^a TOKO UNIVERSITY   (Taiwan)

^b CHIENKUO TECHNOLOGY UNIVERSITY   (Taiwan)

^c ASIA UNIVERSITY   (Taiwan)

^d NATIONAL TAIWAN OCEAN UNIVERSITY   (Taiwan)

Author keywords

Cholestin; Liver function; Oxidized cholesterol; Rats; Toxic effect

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; CHOLESTIN; GLUTATHIONE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; XUEZHIKANG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY WEIGHT; CONTROLLED STUDY; DIETARY INTAKE; KIDNEY MASS; LIVER TOXICITY; LIVER WEIGHT; MALE; NONHUMAN; RAT;

RATTUS;

EID: 77955881524     PISSN: 10219498     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Havel, R. J. 1999. Dietary supplement or drug? The case of cholestin. Am. J. Clin. Nutr. 70: 106-108.
2. Li, C., Zhu, Y., Wang, Y., Zhu, J. S., Chang, J. and Kritchevsky, D. 1998. Monascus purpureus-fermented rice (red yeast rice): a natural food product that lowers blood cholesterol in animal models of hypercholesterolemia. Nutr. Res. 18: 71-81.
3. Ma, J., Li, Y., Ye, Q., Li, J., Hua, Y., Ju, D., Zhang, D., Cooper, R. and Chang, M. 2000. Constituents of red yeast rice, a traditional Chinese food and medicine. J. Agric. Food Chem. 48: 5220-5225.
4. Wang, J., Lu, Z., Chi, J., Wang, W., Su, M., Kou, W., Yu, P., Yu, L., Chen, L., Zhu, J. S. and Chang, J. 1997. Multicenter clinical trial of serum lipid-lowering effects of a Monascus purpureus (red yeast) rice preparation from traditional Chinese medicine. Curr. Ther. Res. Clin. Exp. 58: 964-978.
5. Heber, D., Yip, I., Ashley, J. M, Elashoff, D. A., Elashoff, R. M. and Go, V. L. 1999. Cholesterol-lowering effects of a proprietary Chinese red-yeast-rice dietary supplement. Am. J. Clin. Nutr. 69: 231-236.
6. Qin, S., Zhang, W., Qi, P., Zhao, M., Dong, Z., Li, Y., Xu, X., Fang, X., Fu, L., Zhu, J. S. and Chang, J. 1999. Elderly patients with primary hyperlipidemia benefited from treatment with a Monascus purpureus rice preparation: a placebo-controlled, double-blind clinical trial. The 39th Annual Conference on Cardiovascular Disease Epidemiology and Prevention, Poster presentations (P89), Orlando, Florida, USA, March 24-27. Circulation 99: 1123.
7. Rippe, J., Bonovich, K., Colfer, H., Davidson, M., Dujovne, C., Fried, D., Greenspan, M., King, S., Karlsberg, R., LaForce, C., Litt, M. and McGhee, J. R. 1999. A multicenter, self-controlled study of cholestin in subjects with elevated cholesterol. The 39th Annual Conference on Cardiovascular Disease Epidemiology and Prevention, Poster presentations (P88), Orlando, Florida, USA, March 24-27. Circulation 99: 1123.
8. Jian, J. B., Hao, X. Y., Deng, C. Q., Zhou, H. T. and Lin, J. 1999. The effects of Xuezhikang on serum lipid profile, thromboxane A (2) and prostacyclin in patients with hyperlipoidemia. Zhonghua Nei Ke Za Zhi 38: 517-519.
9. Journoud, M. and Jones, P. J. 2004. Red yeast rice: a new hypolipidemic drug. Life Sci. 74: 2675-2683.
10. SoRelle, R. 2000. Appeals court says Food and Drug Administration can regulate cholestin. Circulation 102: E9012-E9013.
11. Mei, F. 1990. Red yeast flavored duck. In "Fang Mei's Illustrated Cookbook of Regional Chinese Cuisine." pp. 177-188. Guangxi National Press. Guangxi, China.
12. Stuart, G. A. 1979. Chinese Materia Medica-vegetable kingdom. Southern Material Center, Inc, Taipei, Taiwan, R.O.C.
13. Brosche, T., Kral, C., Summa, J. D. and Platt, D. 1996. Effective lovastatin therapy in elderly hypercholesterolemic patients-an antioxidative impact? Arch. Gerontol. Geriatr. 22: 207-221.
14. Zhang, M. and Duan, Z. X. S. 1998. Active components of Xuezhikang. Chin. J. New Drugs 7: 213-214.
15. Tobert, J. A., Bell, G. D., Birtwell, J., James, I., Kukovetz, W. R., Pryor, J. S., Buntinx, A., Holmes, I. B., Chao, Y. S. and Bolognese, J. A. 1982. Cholesterol-lowering effect of mevinolin, an inhibitor of 3-hydroxy-3-methyl- glutaryl-coenzyme A reductase, in healthy volunteers. J. Clin. Invest. 69: 913-919.
16. Tsuji, K., Ichikawa, T., Tanabe, N., Abe, S., Tarui, S. and Nakagawa, Y. 1992. Effects of two kinds of koji on blood pressure in spontaneously hypertensive rats. Nippon Nogeikagaku Kaishi 66: 1241-1246.
17. Wang, L., Mo, H. and Shi, H. 1999. Production of lovastatin with solid-state fermentation of Monascus ruber (in Chinese). Zhongguo Kang Sheng Su Za Zhi 24: 96-98.
18. Katan, M. B., Zock, P. L. and Mensink, R. P. 1994. Effects of fats and fatty acids on blood lipids in humans: an overview. Am. J. Clin. Nutr. 60: 1017S-1022S.
19. Su, C. F., Liu, I. M. and Cheng, J. T. 2007. Improvement of insulin resistance by Hon-Chi in fructose-rich chow-fed rats. Food Chem. 104: 45-52.
20. Endo, A. 1979. Monacolin K, a new hypocholesterolemic agent produced by a Monascus species. J. Antibiot. 32: 852-854.
21. Endo, A., Hasumi, K., Negishi, S. and Monacolins, J. L. 1985. New inhibitors of cholesterol biosynthesis produce hypocholesterolemic and antiatherogenic effect of Monascus purpureus-fermented rice (red yeast rice) in cholesterol fed rabbits. J. Antibiot. 338: 420-422.
22. Wang, I. K., Lin-Shiau, S. Y., Chen, P. C. and Lin, J. K. 2000. Hypotriglyceridemic effect of Anka (a fermented rice product of Monascus sp.) in rats. J. Agric. Food Chem. 48: 3183-3189.
23. Yan, P. S. and White, P. J. 1990. Cholesterol oxidation in heated lard enriched with two levels of cholesterol. J. Am. Oil Chem. Soc. 67: 927-931.
24. Zunin, P., Evangelsti, F., Caboni, M. F., Penazzi, G., Lercker, G. and Tiscorna, E. 1995. Cholesterol oxidation in baked foods containing fresh and powdered eggs. J. Food Sci. 60: 913-915.
25. Osada, K., Kodama, T., Cui, L., Yamada, K. and Sugano, M. 1993. Levels and formation of oxidized cholesterols in processed marine foods. J. Agric. Food Chem. 41: 1893-1898.
26. Paniangvait, P., King, A. J., Jone, A. D. and German, B. G. 1995. Cholesterol oxides in foods of foods of animal origin. J. Food Sci. 60: 1159-1174.
27. Addis, P. B. 1986. Occurrence of lipid oxidation products in foods. Food Chem. Toxicol. 24: 1021-1030.
28. Vine, D. F., Mamo, C. L., Beilin, L. J., Mori, T. A. and Croft, K. D. 1998. Dietary oxysterols are incorporated in plasma triglyceride rich lipoproteins, increase their susceptibility to oxidation and increase aortic cholesterol concentration of rabbits. J. Lipid Res. 39: 1995-2004.
29. Lyons, M. A., Samman, S., Gatto, L. and Brown, A. J. 1999. Rapid hepatic metabolism of 7-ketocholesterol in vivo: implications for dietary oxysterols. J. Lipid Res. 40: 1846-1857.
30. Osada, K., Kodama, T., Noda, S., Yamada, K. and Sugano, M. 1995. Oxidized cholesterol modulates age-related change in lipid metabolism in rats. Lipids 30: 405-413.
31. th edition. pp. 242-273. Helrich, K. ed.. AOAC. Washington, DC. http://ag.arizona.edu/azaqua/ista/ista6/ista6web/pdf/264.pdf
32. American Institute of Nutrition. 1977. Report of the American Institute of nutrition. ad hoc committee on standards for nutritional studies. J. Nutr. 107: 1340-1348.
33. Tatum, V. L., Changchit, C. and Chow, C. K. 1990. Measurement of malondialdehyde by high performance liquid chromatography with fluorescence detection. Lipids 25: 226-229.
34. Griffith, O. W. 1980. Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal. Biochem. 106: 207-212.
35. Yeh, Y. H., Wang, D. Y., Deng, J. F., Chen, S. K. and Hwang, D. F. 2003. Effect of chenodeoxycholic acid on the toxicity of 5α-cyprinol sulfate in rats. Toxicology 179: 21-28.
36. Puri, S. C. and Mullen, K. 1980. Multiple comparisons. In "Applied statistics for food and agricultural scientists." pp. 146-162. Hall, G. K. ed.. Medical Publishers. Boston, U. S. A.
37. Ronald, L. and Koretz, M. D. 1992. Chronic hepatitis: science and superstition. In "Current Hepatology." Gitnick, G. ed. Mosby-Year. Chicago, U. S. A.
38. Paniangvait, P., King, A. J., Jone, A. D. and German, B. G. 1995. Cholesterol oxides in foods of foods of animal origin. J. Food Sci. 52: 57-62.
39. Chen, X. Q. 1982. Ben Cao Gang Mu and later works. Chinese Pharm. Bul. 9: 38-42.
40. Rhyu, M. R., Kim, D. K., Kim, H. Y. and Kim, B. K. 2000. Nitric oxide-mediated endothelium-dependent relaxation of rat thoracic aorta induced by aqueous extract of red rice fermented with Monascus ruber. J. Ethnopharmacol. 70: 29-34.
41. Wei, W., Li, C., Wang, Y., Su, H., Zhu, J. S. and Kritchevsky, D. 2003. Hypolipidemic and anti-atherogenic effects of long-term cholestin (Monascus purpureus-fermented rice, red yeast rice) in cholesterol fed rabbits. J. Nutr. Biochem. 14: 314-318.
42. Heber, D., Lembertas, A., Lu, Q. Y., Bowerman, S. and Go, V. L. 2001. An analysis of nine proprietary Chinese red yeast rice dietary supplements: implications of variability in chemical profile and contents. J. Altern. Complement. Med. 7: 133-139.
43. Zhao, S. P., Liu, L., Cheng, Y. C., Shishehbor, M. H., Liu, M. H., Peng, D. Q. and Li, Y. L. 2004. Xuezhikang, an extract of cholestin, protects endothelial function through anti-inflammatory and lipidlowering mechanisms in patients with coronary heart disease. Circulation 110: 915-920.
44. Keithley, J. K., Swanson, B., Sha, B. E., Zeller, J. M., Kessler, H. A. and Smith, K. Y. 2002. A pilot study of the safety and efficacy of cholestin in treating HIV-related dyslipidemia. Nutrition 18: 201-204.
45. Yasukawa, K., Takahashi, M., Yamanouchi, S. and Takido, M. 1996. Inhibitory effect of oral administration of Monascus pigment on tumor promotion in two-stage carcinogenesis in mouse skin. Oncology 53: 247-249. (Pubitemid 26131950)
46. Kou, W., Lu, Z. and Guo, J. 1997. Effect of xuezhikang on the treatment of primary hyperlipidemia. Zhonghua Nei Ke Za Zhi 36: 529-531. (Article in Chinese)
47. Wang, J., Lu, Z., Chi, J., Wang, W., Su, M., Kou W., Yu, P., Yu, L., Chen, L., Zhu, J. S. and Chang, J. 1997. Multi-center clinical trial of the serum lipid lowering effects of a Monascus purpureus (red yeast) rice preparation from traditional Chinese medicine. Curr. Ther. Res. Clin. Exp. 58: 964-978.
48. Man, R. Y., Lynn, E. G., Cheung, F., Tsang, P. S. and O, K. 2002. Cholestin inhibits cholesterol synthesis and secretion in hepatic cells (hepG2). Mol. Cell. Biochem. 233: 153-158.
49. Zhao, S. P., Liu, L., Cheng, Y. C. and Li, Y. L. 2003. Effect of Xuezhikang, a cholestin extract, on reflecting postprandial triglyceridemia after a high-fat meal in patients with coronary heart disease. Atherosclerosis 168: 375-380.
50. Bliznakov, E. G. 2000. More on the Chinese red-yeast-rice supplement and its cholesterol-lowering effect. Am. J. Clin. Nutr. 71: 152-154.
51. Casini, A. F., Pompella, A. and Comporti, M. 1985. Liver glutathione depletion induced by bromobenzene, iodobenzene and diethylmaleate poisoning and its relation to lipid peroxidation and necrosis. Am. J. Pathol. 118: 225-237.
52. Maellaro, E., Casini, A. F., Bello, B. D. and Comporti, M. 1990. Lipid peroxidation and antioxidant systems in the liver injury produced by gluthathione depleting agents. Biochem. Pharmacol. 39: 1513-1521.
53. Meister, A. 1983. Selective modification of glutathione metabolism. Science 22: 472-477.
54. Meister, A. and Anderson, M. E. 1983. Glutathione. Annu. Rev. Biochem. 52: 711-760.
55. Gutteridg, J. M. C. 1995. Lipid peroxidation and antioxidant as biomarkers of tissue damage. Clin. Chem. 14: 1819-1828.
56. Al Khader, A., Al Sulaiman, M., Kishore, P. N., Morais, C. and Tariq, M. 1996. Quinacrine attenuates cyclosporine-induced nephrotoxicity in rats. Transplantation 62: 427-435.
57. Ghadermarzi, M. and Moosavi-Movahedi, A. A. 1996. Determination of the kinetic parameters for the "suicide substrate" inactivation of bovine liver catalase by hydrogen peroxide. J. Enzym. Inhib. 10: 167-175.
58. Chiueh, C. C. and Rauhala, P. 1999. The redox pathway of S-nitrosoglutathione, glutathione and nitric oxide in cell to neuron communications. Free Radic. Res. 31: 641-650.